Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients-implications for treatment

Clinical Microbiology and Infection

Volumn 20, Issue 3, 2014, Pages 235-241

  Pettersson, L ^a   Thunberg, T ^a   Rocklov J ^a   Klingstrom J ^b   Evander, M ^a   Ahlm, C ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Age; Disease severity; Haemorrhagic fever with renal syndrome; Hantavirus; Humoral immune response; Immunoglobulins; Neutrophil; Puumala virus; Viral load; White blood cell count

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; COMPARATIVE STUDY; DISEASE SEVERITY; FATALITY; FEMALE; FOLLOW UP; HANTAVIRUS INFECTION; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PUUMALA VIRUS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VIRUS LOAD; VIRUS PATHOGENESIS; WESTERN HEMISPHERE; AGED; BLOOD; GENETICS; IMMUNOLOGY; SEVERITY OF ILLNESS INDEX; VIROLOGY;

HANTAVIRUS; PUUMALA VIRUS;

ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PUUMALA VIRUS; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 84893758476     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12259     Document Type: Article

References (30)

1. Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis 2003; 3: 653-661.
2. Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 2010; 23: 412-441.
3. Kim YK, Lee SC, Kim C, Heo ST, Choi C, Kim JM. Clinical and laboratory predictors of oliguric renal failure in haemorrhagic fever with renal syndrome caused by Hantaan virus. J Infect 2007; 54: 381-386.
4. Libraty DH, Makela S, Vlk J et al. The degree of leukocytosis and urine GATA-3 mRNA levels are risk factors for severe acute kidney injury in Puumala virus nephropathia epidemica. PLoS ONE 2012; 7: e35402.
5. Dolgin E. Hantavirus treatments advance amidst outbreak in US park. Nat Med 2012; 18: 1448.
6. Rusnak JM, Byrne WR, Chung KN et al. Experience with intravenous Ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res 2009; 81: 68-76.
7. Korva M, Saksida A, Kunilo S, Vidan Jeras B, Avsic-Zupanc T. HLA-associated hemorrhagic fever with renal syndrome disease progression in Slovenian patients. Clin Vaccine Immunol 2011; 18: 1435-1440.
8. Mackow ER, Gavrilovskaya IN. Hantavirus regulation of endothelial cell functions. Thromb Haemost 2009; 102: 1030-1041.
9. Björkström NK, Lindgren T, Stoltz M et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 2011; 208: 13-21.
10. Lindgren T, Ahlm C, Mohamed N, Evander M, Ljunggren HG, Bjorkstrom NK. Longitudinal analysis of the human T cell response during acute hantavirus infection. J Virol 2011; 85: 10252-10260.
11. Sadeghi M, Eckerle I, Daniel V, Burkhardt U, Opelz G, Schnitzler P. Cytokine expression during early and late phase of acute Puumala hantavirus infection. BMC Immunol 2011; 12: 65.
12. Saksida A, Wraber B, Avsic-Zupanc T. Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect Dis 2011; 11: 142.
13. Saksida A, Duh D, Korva M, Avsic-Zupanc T. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis 2008; 197: 681-685.
14. Terajima M, Hendershot JD 3rd, Kariwa H et al. High levels of viremia in patients with the hantavirus pulmonary syndrome. J Infect Dis 1999; 180: 2030-2034.
15. Xiao R, Yang S, Koster F, Ye C, Stidley C, Hjelle B. Sin nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis 2006; 194: 1403-1409.
16. Yi J, Xu Z, Zhuang R et al. Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity. J Infect Dis 2012; 207: 1457-1461.
17. Huggins JW, Hsiang CM, Cosgriff TM et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991; 164: 1119-1127.
18. Mertz GJ, Miedzinski L, Goade D et al. Placebo-controlled, double-blind trial of intravenous Ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 2004; 39: 1307-1313.
19. Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 2000; 182: 43-48.
20. MacNeil A, Comer JA, Ksiazek TG, Rollin PE. Sin Nombre virus-specific immunoglobulin M and G kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome. J Infect Dis 2010; 202: 242-246.
21. de Carvalho Nicacio C, Bjorling E, Lundkvist A. Immunoglobulin A responses to Puumala hantavirus. J Gen Virol 2000; 81: 1453-1461.
22. Hedman K, Vaheri A, Brummer-Korvenkontio M. Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet 1991; 338: 1353-1356.
23. Sundberg E, Hultdin J, Nilsson S, Ahlm C. Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness. PLoS ONE 2011; 6: e21134.
24. Evander M, Eriksson I, Pettersson L et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol 2007; 45: 2491-2497.
25. Pettersson L, Rasmuson J, Andersson C, Ahlm C, Evander M. Hantavirus-specific IgA in saliva and viral antigen in the parotid gland in patients with hemorrhagic fever with renal syndrome. J Med Virol 2011; 83: 864-870.
26. Hjertqvist M, Klein SL, Ahlm C, Klingstrom J. Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis 2010; 16: 1584-1586.
27. Klein SL, Marks MA, Li W et al. Sex differences in the incidence and case fatality rates from hemorrhagic fever with renal syndrome in China, 2004-2008. Clin Infect Dis 2011; 52: 1414-1421.
28. Rasmuson J, Pourazar J, Linderholm M, Sandstrom T, Blomberg A, Ahlm C. Presence of activated airway T lymphocytes in human Puumala hantavirus disease. Chest 2011; 140: 715-722.
29. Brocato R, Josleyn M, Ballantyne J, Vial P, Hooper JW. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS). PLoS ONE 2012; 7: e35996.
30. Klingström J, Stoltz M, Hardestam J, Ahlm C, Lundkvist A. Passive immunization protects cynomolgus macaques against Puumala hantavirus challenge. Antivir Ther 2008; 13: 125-133.